Your browser doesn't support javascript.
loading
Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma.
van Wezel, Esther M; Stutterheim, Janine; Vree, Florentien; Zappeij-Kannegieter, Lily; Decarolis, Boris; Hero, Barbara; Berthold, Frank; Schumacher-Kuckelkorn, Roswitha; Simon, Thorsten; Fiocco, Marta; Voermans, Carlijn; van Noesel, Max M; Caron, Huib N; van der Schoot, C Ellen; Tytgat, Godelieve A M.
Afiliação
  • van Wezel EM; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands and Landsteiner Laboratory of the AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Stutterheim J; Department of Pediatric Oncology, Emma Children's Hospital, Academical Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Vree F; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands and Landsteiner Laboratory of the AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Zappeij-Kannegieter L; Department of Pediatric Oncology, Emma Children's Hospital, Academical Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Decarolis B; Department of Pediatric Oncology, Emma Children's Hospital, Academical Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Hero B; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands and Landsteiner Laboratory of the AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Berthold F; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Cologne, Germany.
  • Schumacher-Kuckelkorn R; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Cologne, Germany.
  • Simon T; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Cologne, Germany.
  • Fiocco M; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Cologne, Germany.
  • Voermans C; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Cologne, Germany.
  • van Noesel MM; Department of Biostatistics, Leiden University Medical Center and Dutch Childhood Oncology Group, The Hague, Netherlands.
  • Caron HN; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands and Landsteiner Laboratory of the AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van der Schoot CE; Department of Pediatric Oncology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Tytgat GA; Department of Pediatric Oncology, Emma Children's Hospital, Academical Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Pediatr Blood Cancer ; 62(8): 1368-73, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25939774
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasia Residual / Transplante de Células-Tronco / Células Neoplásicas Circulantes / Neuroblastoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasia Residual / Transplante de Células-Tronco / Células Neoplásicas Circulantes / Neuroblastoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Humans / Infant Idioma: En Revista: Pediatr Blood Cancer Assunto da revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda